Steven Pincus obtained his Ph.D.in Biochemistry from the State University of NY at Buffalo. He obtained post-doctoral training in the microbiology department at the State University of NY at Stony Brook. Over his career he has held multiple positions at Virogenetics, Elusys Therapeutics and Novavax where he has developed vaccines and monoclonal antibody therapeutics against viral and microbial targets and supporting these projects with the development of appropriate analytical methods. At Fujifilm Diosynth Biotechnologies Texas ( a CDMO) he is AVP Virology and Analytical Development. He leads teams working with tissue culture, virus propagation and methods transfer/development for multiple clients. Steven Pincus obtained his Ph.D.in Biochemistry from the State University of NY at Buffalo. He obtained post-doctoral training in the microbiology department at the State University of NY at Stony Brook. Over his career he has held multiple positions at Virogenetics, Elusys Therapeutics and Novavax where he has developed vaccines and monoclonal antibody therapeutics against viral and microbial targets and supporting these projects with the development of appropriate analytical methods. At Fujifilm Diosynth Biotechnologies Texas ( a CDMO) he is AVP Virology and Analytical Development. He leads teams working with tissue culture, virus propagation and methods transfer/development for multiple clients.

Vaccines & Vaccination